# DexaFit

> DexaFit is a health-testing company that turns a quick, low-radiation full-body DXA scan into a broad picture of a person's health - body composition, bone density, visceral fat and metabolic markers. Its AI arm, DexaFit Dx, layers machine learning on top of those same scans to screen for major chronic diseases such as coronary artery disease and type 2 diabetes, aiming to catch them early and non-invasively. Founded in Chicago in 2011 and now operating dozens of centers, DexaFit pairs in-person testing with an app that translates results into longevity scores, disease-risk estimates and trackable goals.

- **Founded:** 2011
- **Headquarters:** Edina, Minnesota, United States
- **Founders:** Adam Kadela (Co-Founder, COO/CPO), Matt Ulrich (Co-Founder)
- **Team size:** ~63 employees (LinkedIn); third-party estimates range 25-100
- **Products:** DXA Body Composition Scan, VO2 Max Testing, RMR (Resting Metabolic Rate) Testing, DexaFit App, DexaFit Dx
- **Notable:** Grew from a single Chicago studio (2011) to a nationwide network of testing centers with international expansion plans, Built DexaFit Dx, an AI model trained on over 250,000 scans and 5 billion data points, Reports over 95% accuracy and an under-2% false-positive rate for AI disease screening

## Products & services

- **DXA Body Composition Scan** — A full-body dual-energy X-ray absorptiometry scan measuring body fat, muscle mass (ALMI), visceral fat, regional composition and bone density with minimal radiation exposure.
- **VO2 Max Testing** — Cardiorespiratory fitness assessment measuring maximal oxygen uptake to gauge aerobic capacity and endurance.
- **RMR (Resting Metabolic Rate) Testing** — Metabolic test measuring how many calories the body burns at rest to guide nutrition and weight-management plans.
- **DexaFit App** — Mobile app delivering personalized insights from testing data, including a longevity score, diabetes and heart-disease risk, trend tracking and goal setting.
- **DexaFit Dx** — AI system that analyzes standard DXA scans to screen for major chronic diseases - coronary artery disease, type 2 diabetes and musculoskeletal conditions - reported at over 95% accuracy with an under-2% false-positive rate. Pursuing FDA clearance as a Software as a Medical Device.

## Achievements

- Grew from a single Chicago studio (2011) to a nationwide network of testing centers with international expansion plans
- Built DexaFit Dx, an AI model trained on over 250,000 scans and 5 billion data points
- Reports over 95% accuracy and an under-2% false-positive rate for AI disease screening
- Delivers screening at extremely low radiation exposure (~0.0004 mSv)
- Pursuing FDA clearance as a Software as a Medical Device (SaMD)

## Latest updates

- **2024-10** — Partner locations expanded service menus to bundle RMR metabolic and VO2 max testing alongside DXA scans.
- **2025-01** — DexaFit Dx continuing toward FDA clearance as a Software as a Medical Device; AI early-access sign-ups open, not yet commercially available.

## Links

- Website: https://dexafitdx.com
- LinkedIn: https://www.linkedin.com/company/dexafit-dx
- Instagram: https://www.instagram.com/dexafit_mpls/
- Facebook: https://www.facebook.com/DexaFitMinneapolis/

---

Profile page: https://yespress.io/dexafit
Published by YesPress — https://yespress.io
Last updated: 2026-07-15